Olaris, Inc., is working to fundamentally change how diseases are treated and diagnosed. By leveraging our myOLARIS™ toolbox which combines metabolomics, machine learning and biology we uncover clinically impactful biomarkers.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/19/25 | undisclosed | Strategic |
Bruker Corporation | undisclosed |
